	Capitaux Propres Et Réserves		Date
Acadia Pharmaceuticals	USD 917.27M	94.89M	2025-09
Agios Pharmaceuticals	USD 1.28B	85.22M	2025-09
Akebia Therapeutics	USD 41.59M	12.37M	2025-09
Alnylam Pharmaceuticals	USD 233.89M	16.7M	2025-09
Anika Therapeutics	USD 146.8M	867K	2025-09
Arrowhead Research	USD 568.42M	102.37M	2025-12
AstraZeneca	USD 45.89B	1.17B	2025-09
Bristol-Myers Squibb	USD 18.55B	1.06B	2025-09
Eli Lilly	USD 23.79B	5.52B	2025-09
Enanta Pharmaceuticals	USD 64.72M	14.56M	2025-09
Esperion Therapeutics	USD -451.36M	17.85M	2025-09
Halozyme Therapeutics	USD 503.92M	171.17M	2025-09
Heron Therapeutics	USD 14.88M	42.14M	2025-09
Insmed	USD 945.57M	304.16M	2025-09
J&J	USD 78.47B	0	2025-09
Lexicon Pharmaceuticals	USD 129.44M	6.41M	2025-06
Ligand Pharmaceuticals	USD 950.17M	121.64M	2025-09
Merck	USD 51.85B	2.79B	2025-09
Minerva Neurosciences	USD -34.58M	2.47M	2025-09
Moderna	USD 9.33B	69M	2025-09
Novartis	USD 44.33B	2.28B	2025-09
Pfizer	USD 92.8B	4.11B	2025-09
PTC Therapeutics	USD -155.76M	50.79M	2025-09
Puma Biotechnology	USD 115.27M	10.55M	2025-09
Sangamo BioSciences	USD 19.6M	14.7M	2025-06
Sanofi	EUR 71.71B	1.55B	2025-12
Takeda	JPY 7.64T	513.39B	2025-12
Teva Pharmaceutical Industries	USD 7.91B	664M	2025-12
Ultragenyx Pharmaceutical	USD 9.16M	142.13M	2025-09
Vanda Pharmaceuticals	USD 466M	20.33M	2025-09
Veracyte	USD 1.26B	36.61M	2025-09

Vanda Pharmaceuticals Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.